<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1505257405
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GLADIO
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACECLOFENAC
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MEDPHARMA PHARMACEUTICAL &amp; CHEMICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB16 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>G1odio Tab lent belongs to a group of medicines called nonsteroidal<br />anti-inflammalory drug&amp; (NSAIDs).They have antiinflammatory<br />and painldUer properties CllU8ing a lowering of<br />SM:lliJl&amp; redness (inflammation) and pain. The medicine/active<br />inpedientofOiadio Tablcnt is Ac:eclofenac.<br />Gladio Tablets works by blocking the pmdudian ofhcmm.,.,_<br />like suballmces called prostaglandins. Prollaglandins have many<br />functions in the body ineluding an important role in both the<br />way the body responds to inflammation and also the<br />rcabsotption of calcium in some d.iseues of the bone.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DoD&#39;t tab Gladio tabJea:<br />&bull; if you are in the third trimester of pregnancy or an:<br />breastfeeding your child.<br />&bull; if you are allergic (byper&amp;eDJitive) to aeeclofenac or any of the<br />other componenta in the product.<br />&bull; if acetylsallcylic acid or other non-steroidal anti-inflammaJoty<br />drup have caused you asthma, rhinitis or urticaris or another<br />allergic reaction.<br />&bull; if you have had a ltomacb or duodenal haemorrhage or ulcer<br />or a perforation of the digestive Inlet<br />&bull; if you have haemorrhages or blood disonlen.<br />&bull; if you have severe n=al impainnem.<br />&bull; if you have severe hepatic impairment.<br />&bull; if you suffer ftom severe heart failure.<br />Tab spedal care willa Cladlo tablet<br />&bull; if you plan to become or believe that you could be pregnant<br />&bull; if you have had or are developing an ulcer, haemorrhage or<br />perforation in the stomach or duodenum, which could present<br />through intense or pcraisteut abdominal pain and/or blacll: feces<br />or even have no previous warning symptoma. this risk is<br />greater when high doses and long-term ~ent. are used iD<br />patients with a history of peptic ulcer and iD the elderly. In<br />these cases, your doctor will collllider the possibility of adding<br />a stomach protector aacnt.<br />&bull; if you have a liver condition.<br />&bull; if you suffer ftom renal impairment</p><p>if you have heart problems or have had a cerebral atlacl&lt;<br />(stroke, haemon-hage).<br />Medicine like Gladio can be associated to a m.ocleialely<br />increased risk of heart (&quot;myocardial infarctions&quot;) or cerebnll<br />attacks. This risk is more likely with high doses and long-term<br />treatments.<br />Do not exceed the reCOIIIIDCDded doac and duration of treatment.<br />If you have cardiac problemJ, a history of cerebnll accidcuts, or<br />believe that you could be at<br />risk of suffering these oonditionJ (for instance, if you have high<br />blood pressure, diabetes, high cholesterol or smoke), you should<br />consult your doctor or pharmacist about thia treatment<br />This type of medieiDes can aiJo cause fluid reteution, eapecially<br />iD patients with heart failure and/or high blood presS\Ile<br />(hypertmaion)<br />&bull; if you have had clotting problems (you bleed easily).<br />&bull; tell your doctor if you an: simultaneously taking mediciDe that<br />alter blood clotting such as corticosteroids, oral anticoagulanla<br />or platelet antiaggregants such as acetylsalicylic acid. also<br />inform him or her of the use of other medicine that could<br />incree1c the risk ofb.a.eawrrhage such as corticosteroids and<br />selective serotonin rouptake inlubitor antidepressants.<br />&bull; if you have Crohn&#39;a disease or uloeralive colitis, as medicines<br />like Gladio can 1l:lllal theee conditions worse.<br />&bull; If you are convalescing from an important surgical opemtion.<br />Consult your doctor even if any of the above c:in:umstances bas<br />affected you only once</p><p>TatfD&amp; other medtdDea:<br />Tell your doctor or pharmacist if you&#39;re taking any other<br />mediciDes, or if you&#39;ve taken any n&gt;cently, iDeluding herbal<br />medicines or other medicines you bought without a prescription.</p><p>Some medicines can intezact with Oladio. in these cases, it may<br />be necessary to change the dose or interrupt the treatment with<br />one of the medicines.<br />This ia particularly important if you ore taking lithium, digoxiD,<br />diuretics, antihyper1ensive agents, anticoagulanta, platelet<br />antiaggrepnts, hypoglycacmic agents, metbotn:xate,<br />corticosteroids, acetylsalicylic acid or other DOD-Steroidal antiinflammstory<br />drugs, selective serotonin reuptake inlubitors<br />(SSRI antidepresaants), cyclosporins, mifepristone, tacrolimus<br />or zidovudiru:.<br />Prep.aacy ud breaaHeecllag<br />As the administmion of medicines like Gladio baa been<br />associated to an increased risk of birth def~, its<br />usc i1 not recommended in the first and second trimesters of<br />pregnancy unless it ia absolutely accessary. In these cases, the<br />dose and duration will be the lowest possible.<br />The administmion of Gladio conlraindicated iD the third<br />trimester.<br />Patienta of the childbearing age should consider that medicines<br />like Oladio have been associated to a reduced ability to<br />conceive.<br />Gladio should not be taken in breastfccding.<br />Effeeta on ability to drive and - maehinea:<br />If you faint or suffer ftom vertigo or other central nervous<br />system disonlen, do not drive or use dangerous too.. or<br />machinery while you are taking Oladio<br />U11e ID the elderly<br />Precautions should be taken when treating elderly patients, who<br />iD general~re more likely to<br />suffer from UDdesimblc effects, preaent cardiovuc:ular, kidney<br />or liver flmdion disorders or<br />receive concomitant medication.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Oladio tablet exactly as your doctor has told you.<br />You should chllck with your doctor or pharmacist if you are not<br />sure.<br />Adlllta: 200 mg per day, iD two 100 mg doses, one tablet iD the<br />morning and another at night<br />Children: there ia no clinical data on the use of Oladio in<br />children, so its usc iD this population is not recommended.<br />Elderly patient.: your doctor will tell you how much to take<br />and mould perform periodic controla.<br />Reul lmp.Jrment or heart fallare: your doctor will tell you<br />how much to take and should perform periodic controls.<br />Liver lmp.Jrment: iD patients with liver conditions, the dose of<br />Gladio should be n&gt;duced to lOOmglday.<br />lutruetlou for the correct adllliDIItratloD of tile<br />preparatfGn<br />The tablets should be swallowed whnle with plenty of liquid.<br />They em be taken with food, as<br />the degree of absorption of aceclofenac remainJ unaltered.<br />If yoa tab more Gladlo tablet thu you ahoDld<br />No infonnation is available about the con.sequeaccs of Oladio<br />overdose iD humans. in case of accidental overdose, the drug&#39;s<br />absorption ahould be J=VCilled by gamic lavage and treatment<br />with activated charcoal.<br />It should be treated from a symptomatic perspective, combating<br />gaatrointestin&amp;l irritation, n=al impairment, hypotension,<br />respiratory distress and convulsions.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines Oladio tablet can cause side effects although<br />not everybody sets them.<br />Most of than an: mild and disappear when the medication is<br />onopped.</p><p>The andellrable effeeta that caa appear with Gladlo coDIIri<br />of:<br />Common (afJeetlng from 1 tv 10 of every 100 patient.)<br />&bull; gastric discomfort abdominal pain. nauaea and diarrhoea<br />the most common undesirable effects oocurring with<br />mediciDes like Gladio (NSAIDs) are gaatroiDtestiDal: peptic<br />ulcers, perforations (fatal, in some ca!ICa), particularly iD the<br />elderly<br />&bull;di2zines&bull;<br />&bull; elevated liver enz;ymca<br />Uacommoa (afJeetia&amp; from 1 to 11 of every 1000 patieata)<br />&bull; gas, in11ammation of the stomach, CODJtipation, vamitiag and<br />mouth ulcers<br />&bull;ik:hing, 11111hand infWnmationofthe skin (dcrmatitia)<br />&bull; elevated urea, elevated creatiniDe<br />Rare (afrectlnc from 1 to 10 of every 10000 patieDb)<br />&bull; blood in the feces<br />&bull; facial swelling<br />&bull; heart failure, high blood pressure<br />medieiDes like Gladio can be particularly associated to a<br />moderately increased risk of suffering a heart (&quot;myocardial<br />infarction&quot;) or cerebnll altack.<br />&bull;anaemia<br />&bull; severe alJCllPc reaction, allergies<br />&bull; sight disorders<br />&bull; breathing difficulties<br />Very rare (affeetiD&amp;I&bull; tba 1 out of every 10000 patients)<br />&bull; inilammationofthe mucous membiaae of the mouth, digestive<br />haemorrhage, int11111l1J18tion of the pa.DCR:as, inU:stinal<br />perforation.<br />Cases of ulcerative colitia and Crohn&#39;s disease have been seen tD<br />get worse.</p><p>&bull; pUJplish blemiahca on the akin, IJeVere skiD reactions<br />On very rare occasiollll, PMOIS48.RO<br />medicines like Oladio em be Last Rev. Date: 0612019<br />aseociated to very IICVere akin<br />blistering reactions such as Stevens-Johnson syndrome and<br />Toxic Epidermal Nca-olyais.<br />&bull; palpitations, reddening of the skin, heat, liquid reten1ion<br />(oedemas)<br />&bull;liver damage (including hepatitis).<br />Medicines like Oladio can be associated to liver disorders<br />causing yellowing of the aida and eyes, occasinaally with high<br />fever or swelling and scasitivity of the upper abdomen. Suspend<br />the treatment and tell your doctor immediately if you notice<br />jaomdice(ycUowiDg) of the akin or eyes.<br />&bull; Reduced white blood cells, reduced platelets, bone :awrow<br />depression, haemolytic anaemia.<br />&bull; increa!ICd blood potassium<br />&bull; depression, sleep disoniers, clifficulty falling asleep<br />&bull; tingliDg senaation, drowsiness, headacbe, taste disorders,<br />tremors<br />&bull;vertigo.<br />&bull; wheezing, bronchospasm<br />&bull;leg cramps<br />&bull; altered kidney function (nephrotic syndrome), n=al<br />impairment<br />&bull; fatigue, liquid retention (oedema)<br />&bull; elevated alksline phosphatase, weight gain<br />If any of the s.ide effects get 1Crioll8 or if you notice any side<br />effects not lilted in thia leaflet, please tell your doctor or<br />pharmacist.<br />To report uy llde dleets plea11e coatact:<br />National Pharmacovigi]ance Center (NPC)<br />Fax: +966-11-205 7662<br />E-mail: DDC.drug@!fduov.sa<br />Website: www,afda,KPy.aahtpc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not lltore above 30&quot;C.<br />&bull; Usc the product witbiD 90 days from the first openiDg.<br />&bull; Keep out of reach of children.<br />&bull; Do not use after the expiry&#39; date stated on the label.<br />-Do not use if there is my physical change on the product<br />- Medicines should not be disposed of via wastewater or<br />household waste. Ask your pharmacist how to dispose of<br />medicines no longer required. these meuures will help to<br />protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Gladle tablet c:ontabu:<br />Eaeh film c:eated tablet contaiDs:<br />Aetlve fDcndleat IJ: Aceclofenac I OOmg.<br />J:a-Actlve J:a&amp;redlents: Microclylllalline Cellulose,<br />Croacarmellosc Sodium. Povidone K-30, MagDesima Stearate<br />and Ethanol.<br />For film coatill&amp;: Opadry n (OY-LS-28908 White) and Purified<br />Water.<br />What Gladio tablet Ioobllke and coDteats of the pack<br />Oladio tablets are white to off-white, round, biconvex film<br />coated tablet ~ved with &#39;M07&#39; on one side and having plain<br />surface on the other aide.<br />20 tableta packed iD HOPE bottle with white plastic childproof<br />desiccant cap, inaide a box along with a leafleL</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Gladle tablet c:ontabu:
Eaeh film c:eated tablet contaiDs:
Aetlve fDcndleat IJ: Aceclofenac I OOmg.
J:a-Actlve J:a&redlents: Microclylllalline Cellulose,
Croacarmellosc Sodium. Povidone K-30, MagDesima Stearate
and Ethanol.
For film coatill&: Opadry n (OY-LS-28908 White) and Purified
Water.
What Gladio tablet Ioobllke and coDteats of the pack
Oladio tablets are white to off-white, round, biconvex film
coated tablet ~ved with 'M07' on one side and having plain
surface on the other aide.
20 tableta packed iD HOPE bottle with white plastic childproof
desiccant cap, inaide a box along with a leafleL
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medpharma Pbarma. &amp; Chern. Ind&#39;S (L.L.C.)<br />P.O. Box:2S23S, Industrial Area No: 13, Street No: 37, Shllljab,<br />U.A.E.<br />Tel: +971 6 S14 8801<br />Fax: +9716 S44 OSOO<br />E-mail: infomedplumna@va!eant com<br />For any infonnatioa about this medicinal prndad, pleue<br />contact the local representative of the Marketing<br />Aatllortzattoa Holder:<br />ZIMMO TRADING CO.LTD.<br />8, AI-Washm SL, AJ.Murahba Square, Riyadh. KSA.<br />Tel: +9661 4021068<br />Fax: +9661 4021986<br />E-mail: iDfo@zimmq.ne!</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>na</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            na
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gladio 100
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active Ingredient: Each film coated tablet contains 100mg Aceclofenac.
Inactive Ingredients: : Microcrystalline Cellulose, Croscarmellose Sodium, Povidone K,
Magnesium Stearate, Ethanol.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gladio 100 mg Film-coated Tablets is indicated for the relief of pain and inflammation in<br />osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Undesirable effects may be minimised by using the lowest effective dose for the shortest<br />duration necessary to control symptoms (see section 4.4).<br />Adults<br />The recommended dose is 200 mg daily, taken as two separate 100 mg doses, one tablet in<br />the morning and one in the evening.<br />Children<br />There are no clinical data on the use of Aceclofenac 100 mg Tablets in children and<br />therefore it is not recommended for use in children.</p><p>Elderly<br />The elderly, who are more likely to be suffering from impaired renal, cardiovascular or<br />hepatic function and receiving concomitant medication, are at increased risk of the serious<br />consequences of adverse reactions. If an NSAID is considered necessary, the lowest<br />effective dose should be used and for the shortest possible duration. The patient should be<br />monitored regularly for GI bleeding during NSAID therapy.</p><p>The pharmacokinetics of Gladio 100mg Tablets are not altered in elderly patients, therefore<br />it is not considered necessary to modify the dose or dose frequency.<br />Patients with renal impairment<br />There is no evidence that the dosage of Aceclofenac 100 mg Tablets needs to be modified<br />in patients with mild renal impairment, but as with other NSAIDs caution should be<br />exercised (see section4.4).<br />Patients with liver impairment<br />There is some evidence that the dose of Aceclofenac 100 mg Tablets should be reduced in<br />patients with hepatic impairment and it is suggested that an initial daily dose of 100 mg be<br />used.<br />Method of administration<br />Gladio 100 mg Film-coated Tablets are supplied for oral administration and should be<br />swallowed whole with a sufficient quantity of liquid.<br />To be taken preferably with or after food. When Aceclofenac 100 mg Tablets was<br />administered to fasting and fed healthy volunteers only the rate and not the extent of<br />aceclofenac absorption was affected</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to aceclofenac or to any of the excipients listed in section 6.1
Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of
proven ulceration or bleeding).
NSAIDs are contraindicated in patients who have previously shown hypersensitivity
reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin,
or other non-steroidal anti-inflammatory drugs.
Patients with active bleeding or bleeding diathesis.
Severe hepatic failure and renal failure (see section 4.4).
Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral
arterial disease and/or cerebrovascular disease.
History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy.
Aceclofenac 100 mg Tablets should not be prescribed during pregnancy, especially during
the last trimester of pregnancy, in women attempting to conceive and lactation unless there
are compelling reasons for doing so. The lowest effective dosage should be used (see
section 4.6).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest<br />duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks<br />below).<br />The use of Gladio 100 mg Tablets with concomitant NSAIDs including cyclooxygenase-2<br />selective inhibitors should be avoided (see section 4.5).<br />Elderly:<br />The elderly have an increased frequency of adverse reactions to NSAIDs especially<br />gastrointestinal bleeding and perforation which may be fatal (see section 4.2).<br />Respiratory disorders:<br />Caution is required if administered to patients suffering from, or with a previous history of,<br />bronchial asthma since NSAIDs have been reported to precipitate bronchospasm in such<br />patients.</p><p>Cardiovascular, Renal and Hepatic Impairment:<br />The administration of an NSAID may cause a dose dependent reduction in prostaglandin<br />formation and precipitate renal failure. Patients at greatest risk of this reaction are those<br />with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics<br />and the elderly. Renal function should be monitored in these patients (see also section 4.3).<br />Renal:<br />The importance of prostaglandins in maintaining renal blood flow should be taken into<br />account in patients with impaired cardiac or renal function, those being treated with<br />diuretics or recovering from major surgery. Effects on renal function are usually reversible<br />on withdrawal of Gladio 100 mg Tablets.</p><p>Hepatic:<br />If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent<br />with liver disease develop or if other manifestations occur (eosinophilia, rash), Aceclofenac<br />100 mg Tablets should be discontinued. Close medical surveillance is necessary in patients<br />suffering from mild to moderate impairment of hepatic function. Hepatitis may occur<br />without prodromal symptoms.<br />Use of Gladio 100 mg Tablets in patients with hepatic porphyria may trigger an attack.<br />Cardiovascular and cerebrovascular effects:<br />Patients with congestive heart failure (NYHA-I) and patients with significant risk factors<br />for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking)<br />should only be treated with aceclofenac after careful consideration.<br />Appropriate monitoring and advice are required for patients with a history of hypertension<br />and/or mild congestive heart failure (NYHA-I) as fluid retention and oedema have been<br />reported in association with NSAID therapy.<br />As the cardiovascular risks of aceclofenac may increase with dose and duration of<br />exposure, the shortest duration possible and the lowest effective daily dose should be used.<br />The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated<br />periodically.</p><p>Aceclofenac should also be administered with caution and under close medical surveillance<br />to patients with a history of cerebrovascular bleeding<br />Gastrointestinal bleeding, ulceration and perforation:<br />GI bleeding, ulceration or perforation, which can be fatal, has been reported with all<br />NSAIDs at any time during treatment, with or without warning symptoms or a previous<br />history of serious GI events.<br />Close medical surveillance is imperative in patients with symptoms indicative of gastrointestinal<br />disorders, with a history suggestive of gastro-intestinal ulceration, with ulcerative<br />colitis or with Crohn&#39;s disease, bleeding diathesis or haematological abnormalities.<br />The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses,<br />in patients with a history of ulcer, particularly if complicated with haemorrhage or&nbsp;perforation (see section 4.3), and in the elderly. These patients should commence treatment<br />on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol<br />or proton pump inhibitors) should be considered for these patients, and also for patients<br />requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal<br />risk (see below and section 4.5).<br />Patients with a history of GI toxicity, particularly when elderly, should report any unusual<br />abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.<br />Caution should be advised in patients receiving concomitant medications which could<br />increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such<br />as warfarin, selective serotonin-reuptake inhibitors or antiplatelet agents such as aspirin<br />(see section 4.5).<br />When GI bleeding or ulceration occurs in patients receiving aceclofenac, the treatment<br />should be withdrawn.<br />NSAIDs should be given with care to patients with a history of gastrointestinal disease<br />(ulcerative colitis, Crohn&#39;s disease) as these conditions may be exacerbated (see section<br />4.8).<br />SLE and mixed connective tissue disease:<br />In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders<br />there may be an increased risk of aseptic meningitis (see section 4.8).<br />Dermatological:<br />Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-<br />Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in<br />association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk<br />for these reactions early in the course of therapy: the onset of the reaction occurring in the<br />majority of cases within the first month of treatment. Aceclofenac 100 mg Film-coated<br />Tablets should be discontinued at the first appearance of skin rash, mucosal lesions, or any<br />other sign of hypersensitivity.<br />Exceptionally, varicella can trigger serious cutaneous and soft tissues infections<br />complications. To date, the contributing role of NSAIDs in the worsening of these&nbsp;<strong>infections cannot be ruled out. Thus, it is advisable to avoid use of aceclofenac in case of<br />varicella.<br />Impaired female fertility:<br />The use of Aceclofenac 100 mg Tablets may impair female fertility and is not<br />recommended in women attempting to conceive. In women who have difficulties<br />conceiving or who are undergoing investigation of infertility, withdrawal of Aceclofenac<br />100 mg Film-coated Tablets should be considered.<br />Hypersensitivity reactions:<br />As with other NSAIDs, allergic reactions, including anaphylactic/anaphylactoid reactions,<br />can also occur without earlier exposure to the drug.<br />Haematological:<br />Aceclofenac 100 mg Tablets may reversibly inhibit platelet aggregation (see anticoagulants<br />under &#39;Interactions&#39;).<br />Aceclofenac should be avoided in patients who have developed anaemia, agranulocytosis<br />or thrombocytopenia secondary to NSAIDs or metamizol.<br />Long term treatment:<br />All patients who are receiving NSAIDs should be monitored as a precautionary measure<br />e.g. renal failure, hepatic function (elevation of liver enzymes may occur) and blood<br />counts.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Other analgesics including cyclooxygenase-2 selective inhibitors: Avoid concomitant use<br />of two or more NSAIDs (including aspirin) as this may increase the risk of adverse effects<br />(see section 4.4).<br />Anti-hypertensives: Reduced anti-hypertensive effect. The risk of acute renal insufficiency,<br />which is usually reversible, may be increased in some patients with compromised renal<br />function (e.g. dehydrated patients or elderly patients) when ACE- inhibitors or angiotensin<br />II receptor antagonists are combined with NSAIDs. Therefore, the combination should be<br />administered with caution, especially in the elderly. Patients should be adequately hydrated&nbsp;and consideration should be given to monitoring of renal function after initiation of<br />concomitant therapy, and periodically thereafter.<br />Diuretics: Reduced diuretic effect. Diuretics can increase the risk of nephrotoxicity of<br />NSAIDs. Although it was not shown to affect blood pressure control when co-administered<br />with bendrofluazide, interactions with other diuretics cannot be ruled out. When<br />concomitant administration with potassium-sparing diuretics is employed, serum potassium<br />should be monitored.<br />Cardiac glycosides like digoxin:: NSAIDs may exacerbate cardiac failure, reduce GFR<br />(glomerular filtration rate) and increase plasma glycoside levels. The combination should<br />be avoided unless frequent monitoring of glycoside levels can be performed.<br />Lithium: Several NSAIDs drugs inhibit the renal clearance of lithium, resulting in increased<br />serum concentration of lithium. The combination should be avoided unless frequent<br />monitoring of lithium can be performed.<br />Methotrexate: The possible interaction between NSAIDs and methotrexate should be born<br />in mind also when low doses of methotrexate are used, especially in patients with<br />decreased renal function. When combination therapy has to be used, the renal function<br />should be monitored. Caution should be exercised if NSAIDs and methotrexate are<br />administered within 24 hours of each other, since NSAIDs may increase plasma levels,<br />resulting in increased toxicity.<br />Mifepristone: NSAIDs should not be used for 8-12 days after mifepristone administration<br />as NSAIDs can reduce the effect of mifepristone.<br />Corticosteroids: Increased risk of gastrointestinal ulceration or bleeding (see section 4.4).<br />Anti-coagulants: NSAIDs may enhance the effects of anti-coagulants, such as warfarin (see<br />section 4.4). Close monitoring of patients on combined anti-coagulants and Aceclofenac<br />100 mg Film-coated Tablets therapy should be undertaken.<br />Quinolone antibiotics: Animal data indicate that NSAIDs can increase the risk of<br />convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones<br />may have an increased risk of developing convulsions.&nbsp;Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): Increased risk of<br />gastrointestinal bleeding (see section 4.4).<br />Ciclosporin,tacrolimus: Administration of NSAID drugs together with cyclosporin or<br />tacrolimus is thought to increase the risk of nephrotoxicity due to decreased synthesis of<br />prostacyclin in the kidney. During combination therapy it is therefore important to carefully<br />monitor renal function.<br />Zidovudine: Increased risk of haematological toxicity when NSAIDs are given with<br />zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in<br />HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.<br />Antidiabetic agents: Clinical studies have shown that diclofenac can be given together with<br />oral antidiabetic agents without influencing their clinical effect. However, there have been<br />isolated reports of hypoglycaemic and hyperglycaemic effects. Thus with Aceclofenac 100<br />mg Film-coated Tablets, consideration should be given to adjustment of the dosage of<br />hypoglycaemic agents.<br />Other NSAIDs: Concomitant therapy with aspirin or other NSAIDs may increase the<br />frequency of adverse reactions, including the risk of GI bleeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy:<br />There is no information on the use of aceclofenac during pregnancy. Inhibition of<br />prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/fetal<br />development. Data from epidemiological studies suggest an increased risk of miscarriage,<br />cardiac malformation or gastroschisis after use of prostaglandin synthesis inhibitor in early<br />pregnancy. The absolute risk for cardiovascular malformation was increased from less than<br />1%, up to approximately 1.5 %. The risk is believed to increase with dose and duration of<br />therapy.<br />In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in<br />increased pre- and post-implantation loss and embryo-foetal lethality. In addition, increased<br />incidences of various malformations, including cardiovascular, have been reported in<br />animals given a prostaglandin synthesis inhibitor during the organogenetic period. During&nbsp;the first and second trimester of pregnancy, aceclofenac should not be given unless clearly<br />necessary. If aceclofenac is used by a woman attempting to conceive, or during the first and<br />second trimester of pregnancy, the dose should be kept as low and duration of treatment as<br />short as possible.<br />During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose<br />the foetus to:<br />- cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary<br />hypertension);<br />- renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;<br />the mother and the neonate, at the end of pregnancy, to:<br />- possible prolongation of bleeding time, an anti-aggregating effect which may occur even<br />at very low doses.<br />- inhibition of uterine contractions resulting in delayed or prolonged labour.<br />Consequently, aceclofenac is contraindicated during the third trimester of pregnancy (see<br />section 4.3).<br />Lactation<br />There is no information on the secretion of aceclofenac to breast milk; there was however<br />no notable transfer of radio labelled (14C) aceclofenac to the milk of lactating rats.<br />The use of aceclofenac should therefore be avoided in pregnancy and lactation unless the<br />potential benefits to the other outweigh the possible risks to the foetus.<br />Fertility<br />The use of aceclofenac may impair female fertility and is not recommended in women<br />attempting to conceive. In women who have difficulties conceiving or who are undergoing<br />investigation of infertility, withdrawal of Aceclofenac 100 mg Film-coated Tablets should<br />be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are<br />possible after taking NSAIDs. If affected, patients should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrointestinal: The most commonly-observed adverse events are gastrointestinal in<br />nature. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the<br />elderly, may occur (see section 4.4). Nausea, vomiting, diarrhoea, flatulence, constipation,<br />dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of<br />colitis and Crohn&#39;s disease (See section 4.4) have been reported following administration.<br />Less frequently, gastritis has been observed. Pancreatitis has been reported very rarely.<br />Hypersensitivity: Hypersensitivity reactions have been reported following treatment with<br />NSAIDs. These may consist of (a) non-specific allergic reactions and anaphylaxis (b)<br />respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or<br />dyspnoea, or (c) assorted skin disorders, including rashes of various types, pruritus,<br />urticaria, purpura, angiodema and, more rarely exfoliative and bullous dermatoses<br />(including epidermal necrolysis and erythema multiforme).<br />Cardiovascular and cerebrovascular: Oedema, hypertension and cardiac failure have been<br />reported in association with NSAID treatment.<br />Aceclofenac is both structurally related and metabolised to diclofenac for which a greater<br />amount of clinical and epidemiological data consistently point towards an increased risk of<br />general arterial thrombotic events (myocardial infarction or stroke, particularly at high<br />doses and in long treatment). Epidemiological data has also found an increased risk of<br />acute coronary syndrome and myocardial infarction associated with the use of aceclofenac,<br />(see section 4.3 and 4.4).<br />Exceptionally, occurrence of serious cutaneous and soft tissues infections complications<br />during varicella has been reported in association with NSAID treatment.<br />Other adverse reactions reported less commonly include:<br />Renal: Interstitial nephritis.<br />Hepatic: abnormal liver function, hepatitis and jaundice.<br />Neurological and special senses: Optic neuritis, reports of aseptic meningitis (especially in<br />patients with existing auto immune disorders, such as systemic lupus erythematosus, mixed</p><p>connective tissue disease), with symptoms such as stiff neck, headache, nausea, vomiting,<br />fever or disorientation (See section 4.4), confusion, hallucinations, and drowsiness.<br />Haematological: Agranulocytosis, aplastic anaemia.<br />Dermatological: Bullous reactions including Stevens Johnson Syndrome and Toxic<br />Epidermal Necrolysis (very rare). Photosensitivity.<br />If serious adverse reactions occur, Aceclofenac 100 mg film-coated Tablets should be<br />withdrawn.<br />Within the system organ classes, undesirable effects are listed under headings of frequency,<br />using the following categories: very common ((&ge;1/10); common (&ge;1/100 to &lt;1/10);<br />uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), not<br />known (cannot be estimated from the available data). Within each frequency grouping,<br />undesirable effects are presented in order of decreasing seriousness.</p><p>System organ<br />class<br />Common<br />(&ge;1/100 to<br />&lt;1/10)<br />Uncommon<br />(&ge;1/1,000 to<br />&lt;1/100)<br />Rare<br />(&ge;1/10,000 to<br />&lt;1/1,000)<br />Very rare/ isolated reports<br />(&lt;1/10,000)<br />Blood and<br />lymphatic<br />system<br />disorders<br />Anaemia Granulocytopenia<br />Thrombocytopenia<br />Neutropenia<br />Haemolytic anaemia<br />Immune<br />system<br />disorders<br />Anaphylactic<br />reaction<br />(including<br />shock)<br />Hypersensitivity<br />Metabolism<br />and nutrition<br />disorders<br />Hyperkalemia<br />Psychiatric<br />disorders<br />Depression<br />Abnormal dreams<br />Insomnia<br />Nervous<br />system<br />disorders<br />Dizziness Paraesthesia, Tremor<br />Somnolence, Headache<br />Dysgeusia (abnormal taste)<br />Eye disorders Visual<br />disturbance</p><p>Ear and<br />labyrinth<br />disorders<br />Vertigo<br />Tinnitus<br />Cardiac<br />disorders<br />Cardiac failure Palpitations<br />Vascular<br />disorders<br />Hypertension Flushing<br />Hot flush<br />Vasculitis<br />Respiratory,<br />thoracic and<br />mediastinal<br />disorders<br />Dyspnoea Bronchospasm<br />Stridor<br />Gastrointestinal<br />disorders<br />Dyspepsia<br />Abdominal<br />pain<br />Nausea<br />Diarrhoea<br />Flatulence<br />Gastritis<br />Constipation<br />Vomiting<br />Mouth<br />ulceration<br />Melaena<br />Gastrointestinal<br />haemorrhage<br />Gastrointestinal<br />ulceration<br />Stomatitis<br />Intestinal perforation<br />Exacerbation of Crohn&#39;s<br />disease and Colitis Ulcerative<br />Haematemesis<br />Pancreatitis<br />Hepatobiliary<br />disorders<br />Hepatic<br />enzyme<br />increased<br />Hepatic injury (including<br />hepatitis)<br />Jaundice<br />Blood alkaline phosphatase<br />increased<br />Skin and<br />subcutaneous<br />tissue disorders<br />Pruritus<br />Rash<br />Dermatitis<br />Urticaria<br />Angioedema Purpura<br />Severe mucocutaneous skin<br />reaction (including Stevens<br />Johnson Syndrome and Toxic<br />Epidermal Necrolysis)<br />Renal and<br />urinary<br />disorders<br />Blood urea<br />increased<br />Blood<br />creatinine<br />increased<br />Renal failure<br />Nephrotic syndrome<br />General<br />disorders and<br />administration<br />site conditions<br />Oedema<br />Fatigue<br />Cramps in legs<br />Investigations Weight increase</p><p>Reporting of suspected adverse reactions<br />To Report any side effect (s):<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Management of acute poisoning with NSAIDs essentially consists of supportive and<br />symptomatic measures.<br />a) Symptoms<br />Symptoms include headache, nausea, vomiting, epigastric pain, gastrointestinal irritation,<br />gastrointestinal bleeding, rarely diarrhoea, disorientation, excitation, coma, drowsiness,<br />dizziness, tinnitus, hypotension, respiratory depression, fainting, occasionally convulsions.<br />In cases of significant poisoning acute renal failure and liver damage are possible.<br />b) Therapeutic measure<br />Patients should be treated symptomatically as required.<br />Within one hour of ingestion of a potentially toxic amount, activated charcoal should be<br />considered. Alternatively, in adults, gastric lavage should be considered within one hour of<br />ingestion of a potentially life-threatening overdose.<br />Specific therapies such as dialysis or haemoperfusion are probable of no help in eliminating<br />NSAIDs due to their high rate of protein binding and extensive metabolism.<br />Good urine output should be ensured.<br />Renal and liver function should be closely monitored.<br />Patients should be observed for at least four hours after ingestion of potentially toxic<br />amounts.<br />In case of frequent or prolonged convulsions, patients should be treated with intravenous<br />diazepam.</p><p>Other measures may be indicated by the patient&#39;s clinical condition.<br />Management of acute poisoning with oral aceclofenac essentially consists of supportive<br />and symptomatic measures for complications such as hypotension, renal failure,<br />convulsions, gastro-intestinal irritation, and respiratory depression.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5.1 Pharmacodynamic properties<br />Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids,<br />acetic acid derivatives and related substances<br />ATC code: M01AB16.<br />Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic<br />properties.<br />The mode of action of aceclofenac is largely based on the inhibition to prostaglandin<br />synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is<br />involved in the production of prostaglandins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After oral administration, aceclofenac is rapidly and completely absorbed as unchanged<br />drug. Peak plasma concentrations are reached approximately 1.25 to 3.00 hours following<br />ingestion. Aceclofenac penetrates into the synovial fluid, where the concentrations reach<br />approximately 57% of those in plasma. The volume of distribution is approximately 25 L.<br />The mean plasma elimination half-life is around 4 hours. Aceclofenac is highly proteinbound<br />(&gt;99%). Aceclofenac circulates mainly as unchanged drug. 4&#39;- Hydroxyaceclofenac<br />is the main metabolite detected in plasma. Approximately two- thirds of the administered<br />dose is excreted via the urine, mainly as hydroxymetabolites.<br />Aceclofenac is partially metabolised to diclofenac.<br />No changes in the pharmacokinetics of aceclofenac have been detected in the elderly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The results from preclinical studies conducted with aceclofenac are consistent with those<br />expected for NSAIDs. The principal target organ was the gastro-intestinal tract. No<br />unexpected findings were recorded.</p><p>Aceclofenac was not considered to have any mutagenic activity in three in vitro studies and<br />an in vivo study in the mouse.<br />Aceclofenac was not found to be carcinogenic in either the mouse or rat.<br />Animal studies indicate that there was no evidence of teratogenesis in rats although the<br />systemic exposure was low and in rabbits treatment with aceclofenac (10 mg/kg/day)<br />resulted in a series of morphological changes in some fetuses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>6.1 List of excipients<br />In active ingrediants<br />Microcrystalline Cellulose<br />Croscarmellose Sodium<br />Povidone K-30<br />Magnesium Stearate<br />Ethanol<br />Film Coating<br />Opadry II (OY-LS-28908 White)<br />Purified Water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not Store above 30&deg;C.<br />Use this product within 90 days from the first opening.<br />Do not use after the expiry date stated on the label.<br />Do not use if there is any physical change on the product.<br />Keep out of reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gladio is available as 20&rsquo;s tablets packed in HDPE plastic bottle sealed with child proof<br />cap, packed along with leaflet in printed carton box.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special instructions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medpharma Pharmaceutical & Chemical Industries L.L.C
Industrial Area No. 13
Sharjah
United Arab Emirates
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                06/2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>